Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsPridgeon, Chris S
Wong, Min Wei
Heringa, Minne B
Bearon, Rachel N
Wilkinson, Emma L
Hendriks, Delilah F G
Sison-Young, Rowena L
Cross, Mike J
Park, B Kevin
Goldring, Chris E P
MetadataShow full item record
TitleInnovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms.
Published inArch Toxicol 2018; 92(2):557-69
PubliekssamenvattingThe development of improved, innovative models for the detection of toxicity of drugs, chemicals, or chemicals in cosmetics is crucial to efficiently bring new products safely to market in a cost-effective and timely manner. In addition, improvement in models to detect toxicity may reduce the incidence of unexpected post-marketing toxicity and reduce or eliminate the need for animal testing. The safety of novel products of the pharmaceutical, chemical, or cosmetics industry must be assured; therefore, toxicological properties need to be assessed. Accepted methods for gathering the information required by law for approval of substances are often animal methods. To reduce, refine, and replace animal testing, innovative organotypic in vitro models have emerged. Such models appear at different levels of complexity ranging from simpler, self-organized three-dimensional (3D) cell cultures up to more advanced scaffold-based co-cultures consisting of multiple cell types. This review provides an overview of recent developments in the field of toxicity testing with in vitro models for three major organ types: heart, skin, and liver. This review also examines regulatory aspects of such models in Europe and the UK, and summarizes best practices to facilitate the acceptance and appropriate use of advanced in vitro models.
- The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
- Authors: Indans I
- Issue date: 2002 Feb 28
- An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
- Authors: McKim JM Jr, Keller DJ 3rd, Gorski JR
- Issue date: 2012 Dec
- Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
- Authors: Leist M, Lidbury BA, Yang C, Hayden PJ, Kelm JM, Ringeissen S, Detroyer A, Meunier JR, Rathman JF, Jackson GR Jr, Stolper G, Hasiwa N
- Issue date: 2012
- Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
- Authors: EFSA GMO Panel Working Group on Animal Feeding Trials.
- Issue date: 2008 Mar
- Applications of reconstructed skin models in pharmaco-toxicological trials.
- Authors: Damour O, Augustin C, Black AF
- Issue date: 1998 Nov